BIO.News Newsletter

Ending the week with BIO’s letter to President Biden explaining what needs to be done to bolster the Inflation Reduction Act’s historic climate investments, plus what we know—and don’t—about long COVID. (697 words, 3 minutes, 29 seconds)

Football season starts today—and college athletes are kicking off a contest to support rare disease R&D. BIO member Benson Hill recently announced a new partnership to advance high-protein soybeans—with AI, data science, genomics, and biology. Plus, news from D.C. on a key USTR nominee and EUA for monkeypox tests. (729 words, 3 minutes, 38 seconds)

Back to work, back to school—and back to mental health challenges. Mental Health America has insights on the mental health of America’s kids, and resources to help. Plus, the White House is planning for a major food security summit—and we hope biotech is on the menu. (595 words, 2 minutes, 58 seconds)

And we're back. With Congress returning from recess (and BIO returning from a break), we have news on Doug McKalip’s hearing tomorrow in the Senate and news from the break about COVID boosters. (684 words, 3 minutes, 25 seconds)

It’s the last Friday of August—and we’re getting ready to join Congress in a Labor Day recess. Good Day BIO is officially out of office next week, but before we go, we’ve got news and summer reading to kick off the break. Enjoy your holiday—we’ll be back on Tuesday, September 6. (437 words, 2 minutes, 11 seconds)

Today, we look at the rise of deadly, drug-resistant TB—and how policy could help address it—plus, why biotech is an important part of the World Water Week conversation. (588 words, 2 minutes, 56 seconds)

Biotech can help feed the world—but regulatory uncertainty is thwarting the effort, says BIO’s Dr. Michelle McMurry-Heath. Plus, late-stage cervical cancer sees an unnecessary upward trend. (738 words, 3 minutes, 41 seconds)  P.S. BIO’s Michele Oshman interviews Rep. Buddy Carter (R-GA) about how federal policies affect patients during Georgia Bio’s Patient Advocacy Summit today—get the details and register.

We’ve talked a lot about how the Inflation Reduction Act will harm drug R&D—and that’s still true—but today, we look at the good news for ag biotech and climate solutions. Plus, a recent HHS investigation looks at how private Medicare insurers and middlemen steer patients away from cheaper generics. (798 words, 3 minutes, 59 seconds)

Another slow week in Washington, D.C. ahead—but the heat’s on America’s farmers struggling with drought. Meanwhile, we’ve talked a lot about how the Inflation Reduction Act will harm drug R&D—and that’s still true—but today, we look at the silver linings for access to vaccines. (606 words, 3 minutes, 1 second)

Another slow summer Friday in D.C.—but we have the details on what the White House is doing to accelerate access to monkeypox vaccines and treatments, as well as new research on how gene editing led to greater soybean yield. (601 words, 3 minutes)